# 2026-07-05 Stage C-5 Provider Cost Staging Residual Risk Closeout Audit

Task ID: `stage-c-5-provider-cost-staging-residual-risk-closeout-2026-07-05`

Status: closed.

## Audit Scope

This audit reviews the docs-only Stage C residual risk closeout. It does not review or approve Provider readiness,
production pricing, quota defaults, staging/prod, release readiness, final Pass, production usability, or production
readiness.

## Adversarial Checks

| Check                                                                                          | Status |
| ---------------------------------------------------------------------------------------------- | ------ |
| Task is isolated on its own short branch                                                       | pass   |
| Plan lists SSOT/read-gate documents                                                            | pass   |
| Provider freshness is recorded as single-call local evidence, not readiness                    | pass   |
| Cost Calibration is recorded as a bounded local sample, not production pricing                 | pass   |
| Cost/quota package remains discussion-only and does not set defaults                           | pass   |
| Staging remains blocked until target, resource, secret, data, deploy, rollback are explicit    | pass   |
| Evidence excludes raw Prompt, payload, raw AI I/O, full content, secrets, DB rows, screenshots | pass   |
| DB/browser/e2e/dev server/source/test/dependency/schema/staging/prod remain untouched          | pass   |
| No release readiness, final Pass, production usability, or production readiness claim          | pass   |

## Findings

No blocking finding in this docs-only closeout packet.

## Residual Risk

The project now has a clean local Stage C decision surface, but it still has no concrete staging target or production
release contract. The next risky step is staging. It must not be executed from the current local Provider/Cost evidence
alone.

The highest adversarial risk is claim creep: treating local Provider and cost samples as evidence for staging or
production. This packet explicitly blocks that interpretation.

## Non-Claims

- No Provider readiness.
- No production pricing.
- No quota default.
- No staging readiness.
- No release readiness.
- No final Pass.
- No production usability.
- No production readiness.
